Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Solène-Florence Kammerer-Jacquet
Metastatic Clear Cell Renal Cell Carcinoma With a Long-Term Response to Sunitinib: A Distinct Phenotype Independently Associated With Low PD-L1 Expression
Clinical Genitourinary Cancer
Oncology
Urology
Related publications
Long-Term Response to Sunitinib Therapy for Metastatic Renal Cell Carcinoma
Clinical Genitourinary Cancer
Oncology
Urology
Synchronous Metastatic Clear-Cell Renal Cell Carcinoma: A Distinct Morphologic, Immunohistochemical, and Molecular Phenotype
Clinical Genitourinary Cancer
Oncology
Urology
Acanthosis Nigricans Associated With Clear-Cell Renal Cell Carcinoma
Autopsy and Case Reports
A Phase 2 Trial of Sunitinib in Patients With Advanced Non–clear Cell Renal Cell Carcinoma
European Urology
Urology
PD-L1 Inhibition With Avelumab for Metastatic Merkel Cell Carcinoma
Expert Review of Clinical Pharmacology
Medicine
Toxicology
Pharmaceutics
Pharmacology
Potential Roles for PD‐1 and Cabozantinib in Patients With Metastatic Non‐Clear Cell Renal Cell Carcinoma
Oncologist
Cancer Research
Medicine
Oncology
Reversible Myocardial Dysfunction in a Young Woman With Metastatic Renal Cell Carcinoma Treated With Sunitinib
Acta Oncologica
Nuclear Medicine
Radiology
Hematology
Oncology
Medicine
Imaging
Decreased TCL6 Expression Is Associated With Poor Prognosis in Patients With Clear Cell Renal Cell Carcinoma
Oncotarget
Oncology
131 Loss of PD-L1 Expression in Metastatic Merkel Cell Carcinoma Strongly Correlates With a Poor Prognosis
Journal of Investigative Dermatology
Biochemistry
Dermatology
Cell Biology
Molecular Biology
